title: Neuroleptic malignant syndrome caused by combination of risperidone and lithium in a patient with multiple medical comorbidities.
authors.forename: Seyfullah Gorkem
authors.initials: SG
authors.lastname: Kosehasanogullari
authors.forename: Berna
authors.initials: B
authors.lastname: Akdede
authors.forename: Yildiz
authors.initials: Y
authors.lastname: Akvardar
authors.forename: Mert
authors.initials: M
authors.lastname: Akan
authors.forename: Zeliha
authors.initials: Z
authors.lastname: Tunca
mesh_terms: D000747:Anemia, Hypochromic / Q000150:complications; D018692:Antimanic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000150:complications / Q000188:drug therapy; D001971:Bromocriptine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D015600:Glasgow Coma Scale; D006801:Humans; D007037:Hypothyroidism / Q000150:complications; D018020:Lithium Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000150:complications / Q000503:physiopathology*; D011014:Pneumonia / Q000150:complications; D018967:Risperidone / Q000009:adverse effects* / Q000627:therapeutic use; D020246:Venous Thrombosis / Q000150:complications; D017086:beta-Thalassemia / Q000150:complications
chemical_list: D018692:Antimanic Agents; D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D018020:Lithium Compounds; D001971:Bromocriptine; D018967:Risperidone